Cargando…
Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal diagnosis in Hong Kong
BACKGROUND: Chromosomal microarray (CMA) has been shown to be cost-effective over karyotyping in invasive prenatal diagnosis for pregnancies with fetal ultrasound anomalies. Yet, information regarding preceding and subsequent tests must be considered as a whole before the true cost-effectiveness can...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023733/ https://www.ncbi.nlm.nih.gov/pubmed/32059709 http://dx.doi.org/10.1186/s12884-020-2772-y |